Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm
September 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Digital Element Launches New Tools for IP Address Segmentation Mechanisms in Australia - France and Germany on the Horizon
September 03, 2024 21:00 ET
|
Digital Element
ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Digital Element, the global leader in IP geolocation technology, today unveiled the Alternate Area Database (DB), an industry-first enhancement to its...
Bragar Eagel & Squire, P.C. Is Investigating Ibotta, Mynaric, iLearningEngines, and European Wax and Encourages Investors to Contact the Firm
September 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ibotta, Inc. (NYSE:IBTA),...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CAE, Verve, and MongoDB and Encourages Investors to Contact the Firm
September 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Bumble, Cardlytics, and NuScale and Encourages Investors to Contact the Firm
September 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Paragon 28, Inc. (NYSE:...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
September 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ardelyx and Symbotic and Encourages Investors to Contact the Firm
September 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody
September 03, 2024 21:00 ET
|
Shanghai EpimAb Biotherapeutics Co., Ltd.
SHANGHAI and SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, Inc. (“EpimAb” or “EpimAb Biotherapeutics”) a clinical stage biopharmaceutical company specializing in the...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
September 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...